167 related articles for article (PubMed ID: 1610857)
1. Successful treatment of acute humoral rejection in a heart transplant patient.
Malafa M; Mancini MC; Myles JL; Gohara A; Dickinson JM; Walsh TE
J Heart Lung Transplant; 1992; 11(3 Pt 1):486-91. PubMed ID: 1610857
[TBL] [Abstract][Full Text] [Related]
2. Effect of plasmapheresis for acute humoral rejection after heart transplantation.
Wang SS; Chou NK; Ko WJ; Chi NH; Hung SC; Hsu RB; Yu HY; Chen YS; Chu SH; Tsao CI; Shun CT
Transplant Proc; 2006 Dec; 38(10):3692-4. PubMed ID: 17175369
[TBL] [Abstract][Full Text] [Related]
3. Comparison of myocardial cell injury in acute cellular rejection versus acute vascular rejection in cyclosporine-treated heart transplants.
Hook S; Caple JF; McMahon JT; Myles JL; Ratliff NB
J Heart Lung Transplant; 1995; 14(2):351-8. PubMed ID: 7779856
[TBL] [Abstract][Full Text] [Related]
4. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients.
Lones MA; Czer LS; Trento A; Harasty D; Miller JM; Fishbein MC
J Heart Lung Transplant; 1995; 14(1 Pt 1):151-62. PubMed ID: 7727464
[TBL] [Abstract][Full Text] [Related]
5. Heart transplant rejection treated with plasmapheresis.
Partanen J; Nieminen MS; Krogerus L; Harjula AL; Mattila S
J Heart Lung Transplant; 1992; 11(2 Pt 1):301-5. PubMed ID: 1315571
[TBL] [Abstract][Full Text] [Related]
6. Reliability and usefulness of immunofluorescence in heart transplantation.
Bonnaud EN; Lewis NP; Masek MA; Billingham ME
J Heart Lung Transplant; 1995; 14(1 Pt 1):163-71. PubMed ID: 7727465
[TBL] [Abstract][Full Text] [Related]
7. Activation of intravascular macrophages within myocardial small vessels is a feature of acute vascular rejection in human heart transplants.
Ratliff NB; McMahon JT
J Heart Lung Transplant; 1995; 14(2):338-45. PubMed ID: 7779854
[TBL] [Abstract][Full Text] [Related]
8. Utility of surveillance biopsies in infant heart transplant recipients.
Balzer DT; Moorhead S; Saffitz JE; Huddleston CB; Spray TL; Canter CE
J Heart Lung Transplant; 1995; 14(6 Pt 1):1095-101. PubMed ID: 8719456
[TBL] [Abstract][Full Text] [Related]
9. Persistent histologic evidence of rejection in a heart transplant recipient without evidence of graft dysfunction.
Nakhleh RE; Kubo SH; Olivari MT; McDonald K
J Heart Lung Transplant; 1992; 11(1 Pt 1):37-41. PubMed ID: 1540610
[No Abstract] [Full Text] [Related]
10. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
[TBL] [Abstract][Full Text] [Related]
11. Role of routine endomyocardial biopsy to monitor late rejection after heart transplantation.
Spratt P; Sivathasan C; Macdonald P; Keogh A; Chang V
J Heart Lung Transplant; 1991; 10(6):912-4. PubMed ID: 1756155
[TBL] [Abstract][Full Text] [Related]
12. Electric myocardial impedance registration in humoral rejection after heart transplantation.
Grauhan O; Müller J; Knosalla C; Cohnert T; Siniawski H; Volk HD; Fietze E; Kupetz W; Hetzer R
J Heart Lung Transplant; 1996 Feb; 15(2):136-43. PubMed ID: 8672516
[TBL] [Abstract][Full Text] [Related]
13. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
[TBL] [Abstract][Full Text] [Related]
14. Reversibility of cardiac xenograft rejection in primates.
McManus RP; Kinney T; Komorowski R; Hunter J
J Heart Lung Transplant; 1991; 10(4):567-76. PubMed ID: 1911800
[TBL] [Abstract][Full Text] [Related]
15. Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab.
Baran DA; Lubitz S; Alvi S; Fallon JT; Kaplan S; Galin I; Correa R; Courtney MC; Chan M; Spielvogel D; Lansman SL; Gass AL
Transplant Proc; 2004 Dec; 36(10):3164-6. PubMed ID: 15686719
[TBL] [Abstract][Full Text] [Related]
16. Some aspects of changed histopathologic appearance of acute rejection in cardiac allografts after prophylactic application of OKT3.
Kemnitz J; Cremer J; Schaefers HJ; Restrepo-Specht I; Haverich A; Uysal A; Heublein B; Wirth S
J Heart Lung Transplant; 1991; 10(3):366-72. PubMed ID: 1906746
[TBL] [Abstract][Full Text] [Related]
17. Acute rejection and endomyocardial biopsy after heart transplantation.
Urbanová D
Cor Vasa; 1990; 32(5):395-400. PubMed ID: 2286087
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
[TBL] [Abstract][Full Text] [Related]
19. Creatine kinase MB isoforms: a potential predictor of acute cardiac allograft rejection.
Anderson JR; Hossein-Nia M; Brown PA; Corbishley C; Murday AJ; Holt DW
J Heart Lung Transplant; 1995; 14(4):666-70. PubMed ID: 7578173
[TBL] [Abstract][Full Text] [Related]
20. The pathology of transplanted hearts.
Billingham ME
Semin Thorac Cardiovasc Surg; 1990 Jul; 2(3):233-40. PubMed ID: 2081231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
